Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

The global Bell's Palsy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bell's palsy is also called acute idio...

The global Alpers Disease Treatment market size is predicted to grow from US$ 1570 million in 2025 to US$ 2223 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032. United State...

The global Circadian Rhythm Seep Disorder market size is predicted to grow from US$ 837 million in 2025 to US$ 1319 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032. Circadi...

The global Neuroplasticity market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Neuroplast...

The global Developmental and Epileptic Encephalopathies (DEE) Treatment market size is predicted to grow from US$ 7298 million in 2025 to US$ 9325 million in 2032; it is expected to grow at a CAGR of...

The global Developmental and Epileptic Encephalopathies Drug market size is predicted to grow from US$ 7298 million in 2025 to US$ 9325 million in 2032; it is expected to grow at a CAGR of 3.6% from 2...

The global Stuttering Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceutical m...

The global Tardive Dyskinesia Treatment Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Tardive dyski...

The global Long-Acting Injectable (LAI) Antipsychotic market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Long-act...

The global Neuroplasticity Therapy market size is predicted to grow from US$ 886 million in 2025 to US$ 1155 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032. United States...

The global Head Pain Therapy Solutions market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceutic...

The global Cluster Headache Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmace...

The global Developmental Stuttering Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global ph...

The global Dopamine Antagonist market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Dopami...

The global Dopamine Receptor Antagonist market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market f...

The global Tardive Dystonia Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmace...

The global Tardive Dystonia Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceutica...

The global Neurodegenerative Disease Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global...

The global Huntingtons Disease Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States mark...

The global Post-traumatic Stress Disorder Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The g...

The global Attention Deficit Hyperactivity Disorder (ADHD) Treatment market size is predicted to grow from US$ 13680 million in 2025 to US$ 19240 million in 2032; it is expected to grow at a CAGR of 5...

The global Acute Disseminated Demyelination Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United S...

The global Diagnosis and Treatment of Autism Spectrum Disorder market size is predicted to grow from US$ 9721 million in 2025 to US$ 12770 million in 2032; it is expected to grow at a CAGR of 4.0% fro...

The global Migraine Treatment Medication market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Migraine is a neurolo...

The global Autism Spectrum Disorder (ASD) Treatment Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Unit...

According to Stratistics MRC, the Global Gabapentin Market is accounted for $2.6 billion in 2026 and is expected to reach $4.6 billion by 2034 growing at a CAGR of 7.4% during the forecast period. Gab...

According to our (Global Info Research) latest study, the global Guanfacine Hydrochloride API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global Haloperidol Decanoate API market size was valued at US$ 624 million in 2025 and is forecast to a readjusted size of US$ 824 million by...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Aripiprazole market size was valued at US$ 1065 million in 2025 and is forecast to a readjusted size of US$ 1379 m...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Baclofen market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Brivaracetam market size was valued at US$ 920 million in 2025 and is forecast to a readjusted size of US$ 1239 mi...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Safinamide Mesylate market size was valued at US$ 579 million in 2025 and is forecast to a readjusted size of US$...

The Global market for dementia and Alzheimer's disease treatments is anticipated to expand from USD 12.18 billion in 2025 to USD 17.91 billion by 2031, reflecting a compound annual growth rate of 6.64...

According to Stratistics MRC, the Global Antiepileptic Drugs Market is accounted for $22.3 billion in 2026 and is expected to reach $36.9 billion by 2034 growing at a CAGR of 6.5% during the forecast...

According to Stratistics MRC, the Global Tardive Dyskinesia Therapeutics Market is accounted for $3.4 billion in 2026 and is expected to reach $8.0billion by 2034 growing at a CAGR of 11.1% during the...

The global selective serotonin reuptake inhibitors market size was valued at USD 19.51 billion in 2025 and is projected to reach USD 30.25 billion by 2033, growing at a CAGR of 5.70% from 2026 to 2033...

HNY Research projects that the Divalproex Sodium market size will grow from 2505.46 Million USD in 2025 to 3783.56 Million USD by 2031, at an estimated CAGR of 7.11%. The base year considered for the...

According to our (Global Info Research) latest study, the global 5-HT1B/1D Receptor Agonists market size was valued at US$ 1292 million in 2025 and is forecast to a readjusted size of US$ 1663 million...

According to our (Global Info Research) latest study, the global Eletriptan Tablets market size was valued at US$ 151 million in 2025 and is forecast to a readjusted size of US$ 187 million by 2032 wi...

According to our (Global Info Research) latest study, the global Fast-Acting Migraine Medications market size was valued at US$ 3177 million in 2025 and is forecast to a readjusted size of US$ 3862 mi...

According to our (Global Info Research) latest study, the global Migraine-Specific Analgesics market size was valued at US$ 2045 million in 2025 and is forecast to a readjusted size of US$ 2556 millio...

According to our (Global Info Research) latest study, the global Prescription Drugs for Acute Migraine market size was valued at US$ 2045 million in 2025 and is forecast to a readjusted size of US$ 25...

According to our (Global Info Research) latest study, the global Sumatriptan Subcutaneous Injection market size was valued at US$ 181 million in 2025 and is forecast to a readjusted size of US$ 247 mi...

According to our (Global Info Research) latest study, the global Triptan-Class Antimigraine Agents market size was valued at US$ 1292 million in 2025 and is forecast to a readjusted size of US$ 1663 m...

According to our (Global Info Research) latest study, the global Zolmitriptan Preparations market size was valued at US$ 264 million in 2025 and is forecast to a readjusted size of US$ 361 million by...

The global 5-HT1B/1D Receptor Agonists market size is expected to reach $ 1663 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). 5-HT1B/1D Receptor Agonis...

The global Eletriptan Tablets market size is expected to reach $ 187 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032). Eletriptan Tablets are oral solid d...

The global Fast-Acting Migraine Medications market size is expected to reach $ 3862 million by 2032, rising at a market growth of 2.8% CAGR during the forecast period (2026-2032). Fast-acting migraine...

The global Migraine-Specific Analgesics market size is expected to reach $ 2556 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032). Migraine-Specific Analge...

The global Prescription Drugs for Acute Migraine market size is expected to reach $ 2556 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032). Prescription Dr...